Upon the occurrence of a key person event, a suspension period is typically triggered, during which the fund is not able to make new investments. In a previous article, we analyzed the average length of the suspension period and…
more
/ Business Organizations, Finance & Banking
On September 13, 2024, Alteogen announced that it has applied for marketing authorization in Korea for ALT-L9, an aflibercept biosimilar of EYLEA®. According to Alteogen, a 12-country Phase 3 study showed that ALT-L9 met…
more
/ Intellectual Property, Science, Computers, & Technology
On September 13, 2024, the World Health Organization (WHO) announced that it added the first vaccine against monkeypox (mpox) to its prequalification list. The vaccine, MVA-BN, is manufactured by Bavarian Nordic A/S…
more
/ Health, International Law & Trade
Parties facing these issues often propose a MIP reset to realign management’s interests with those of the original (and, if applicable, new) sponsor until the eventual full exit. MIP resets have long been used to rescue…
more
/ Business Organizations, Finance & Banking
On September 9, 2024, approximately one year since its first flurry of similar Marketing Rule actions, the Securities and Exchange Commission (the SEC) announced settlements with nine SEC-registered investment advisers (the…
more
/ Finance & Banking, Securities Law
Revenue-management tools are ubiquitous across sectors, but many hotel owners, operators, and management companies use such tools on a daily basis. As these products have improved, many have incorporated algorithms enabling the…
more
/ Antitrust & Trade Regulation, Commercial Law & Contracts, Real Estate - Residential, Science, Computers, & Technology
Recently, the Delaware Chancery Court and the Third Circuit issued three significant decisions on key issues affecting licensing and M&A transactions in the life sciences industry…
more
/ Business Organizations, Intellectual Property, Mergers & Acquisitions, Science, Computers, & Technology
In the past year, healthcare systems and providers across the country have filed a series of antitrust lawsuits against MultiPlan Inc. and major US health insurers, alleging a hub-and-spoke conspiracy to fix and reduce…
more
/ Antitrust & Trade Regulation, Health, Insurance
On August 30, 2024, Alexion Pharmaceuticals, Inc. and Alexion Pharma International Operations Ltd. (collectively, “Alexion”) and Samsung Bioepis Co. Ltd. (“Samsung Bioepis”) settled their BPCIA dispute related to Samsung…
more
/ Intellectual Property, Science, Computers, & Technology
States are stepping in to regulate AI amid an absence of federal legislation to address fast-changing developments with the technology.
This spring, Colorado became the first state to pass a comprehensive piece of AI…
more
/ Consumer Protection, Privacy, Science, Computers, & Technology
The UK government has released its latest annual report on the National Security and Investment (NSI) Act, covering the period from 1 April 2023 to 31 March 2024. The report outlines key trends, statistics, and developments…
more
/ Antitrust & Trade Regulation, Business Organizations, International Law & Trade, Mergers & Acquisitions
Patience is proving to be a virtue for a private equity industry that began 2024 sitting on more than 28,000 portfolio companies valued at more than $3 trillion, according to a report by Bain & Company, as average hold periods…
more
/ Business Organizations, Finance & Banking, Mergers & Acquisitions, Securities Law
On September 9, 2024, a mediator from the French Financial Markets Authority (AMF) issued conclusions regarding the dispute over the closure of a client’s securities account. The account was closed because the client had failed…
more
/ Finance & Banking, Securities Law
On August 14, 2024, the Federal Trade Commission (“FTC”) published its long-anticipated Final Rule on the Use of Consumer Reviews and Testimonials (“Final Rule”), marking a significant development in the regulation of online…
more
/ Antitrust & Trade Regulation, Consumer Protection
To date, 2024 has not yet seen the type of mega-merger (Pfizer/Seagen) or level of agency enforcement (Sanofi/Maze or Amgen/Horizon) as 2023. But two notable investigations — one still active — show the Federal Trade Commission…
more
/ Antitrust & Trade Regulation, Mergers & Acquisitions, Science, Computers, & Technology
